Inotek Pharmaceuticals Corp (RCKT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The companys trabodenoson is a selective adenosine mimetic that stimulates a specific adenosine subreceptor. Its Trabodenoson technology is a potential new therapy for ocular hypertension (OHT) and primary open-angle glaucoma (POAG) that restores natural state in the eye by mimicking the action of adenosine. The company also sponsors Phase 1, Phase 2 and Phase 3 clinical trials for trabodenoson monotherapy, which have concluded, and Phase 2 clinical trial for trabodenoson plus latanoprost in a fixed-dose combination. IPC is headquartered in Lexington, Massachusetts, the US.

Inotek Pharmaceuticals Corp (RCKT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Inotek Pharma Raises US$21 Million In Venture Financing 11
Partnerships 13
Rocket Pharmaceuticals and Stanford University School of Medicine Enter into Partnership 13
Merger 14
Inotek Pharma Completes Merger with Rocket Pharma 14
Equity Offering 16
Rocket Pharma Plans to Raise up to USD300 Million in Public Offering of Securities 16
Rocket Pharma Prices USD72.8 Million in Public Offering of Shares 17
Inotek Pharma Raises USD4.4 Million in Public Offering of Shares 18
Inotek Pharma Raises USD79.2 Million in Public Offering of Shares 19
Inotek Pharma Raises USD40 Million in IPO 21
Debt Offering 23
Inotek Pharma Raises USD50 Million in Public Offering of 5.75% Notes Due 2021 23
Inotek Pharma Raises USD20 Million in Public Offering of 5% Notes Due 2020 25
Inotek Pharmaceuticals Corp - Key Competitors 27
Inotek Pharmaceuticals Corp - Key Employees 28
Inotek Pharmaceuticals Corp - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 03, 2017: Inotek Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights 30
May 10, 2017: Inotek Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights 31
Mar 16, 2017: Inotek Pharmaceuticals Reports Fiscal Year 2016 Financial Results and Operational Highlights 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List Of Tables


Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inotek Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inotek Pharma Raises US$21 Million In Venture Financing 11
Rocket Pharmaceuticals and Stanford University School of Medicine Enter into Partnership 13
Inotek Pharma Completes Merger with Rocket Pharma 14
Rocket Pharma Plans to Raise up to USD300 Million in Public Offering of Securities 16
Rocket Pharma Prices USD72.8 Million in Public Offering of Shares 17
Inotek Pharma Raises USD4.4 Million in Public Offering of Shares 18
Inotek Pharma Raises USD79.2 Million in Public Offering of Shares 19
Inotek Pharma Raises USD40 Million in IPO 21
Inotek Pharma Raises USD50 Million in Public Offering of 5.75% Notes Due 2021 23
Inotek Pharma Raises USD20 Million in Public Offering of 5% Notes Due 2020 25
Inotek Pharmaceuticals Corp, Key Competitors 27
Inotek Pharmaceuticals Corp, Key Employees 28
Inotek Pharmaceuticals Corp, Subsidiaries 29

List Of Figures


Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Inotek Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Inotek Pharmaceuticals Corp (RCKT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye.

USD 250 View Report

Inotek Pharmaceuticals Corporation Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Inotek Pharmaceuticals Corporation Company Profile is a detailed strategic and analytical report on Inotek Pharmaceuticals Corporation. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Novartis Pharmaceuticals Corp - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and

USD 250 View Report

Adamis Pharmaceuticals Corp (ADMP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available